169 related articles for article (PubMed ID: 28692379)
1. Macrocyclic peptides decrease c-Myc protein levels and reduce prostate cancer cell growth.
Mukhopadhyay A; Hanold LE; Thayele Purayil H; Gisemba SA; Senadheera SN; Aldrich JV
Cancer Biol Ther; 2017 Aug; 18(8):571-583. PubMed ID: 28692379
[TBL] [Abstract][Full Text] [Related]
2. Phenylalanine Stereoisomers of CJ-15,208 and [d-Trp]CJ-15,208 Exhibit Distinctly Different Opioid Activity Profiles.
Brice-Tutt AC; Senadheera SN; Ganno ML; Eans SO; Khaliq T; Murray TF; McLaughlin JP; Aldrich JV
Molecules; 2020 Sep; 25(17):. PubMed ID: 32887303
[TBL] [Abstract][Full Text] [Related]
3. 1Alpha,25-dihydroxyvitamin D3 reduces c-Myc expression, inhibiting proliferation and causing G1 accumulation in C4-2 prostate cancer cells.
Rohan JN; Weigel NL
Endocrinology; 2009 May; 150(5):2046-54. PubMed ID: 19164469
[TBL] [Abstract][Full Text] [Related]
4. c-Myc is a novel target of cell cycle arrest by honokiol in prostate cancer cells.
Hahm ER; Singh KB; Singh SV
Cell Cycle; 2016 Sep; 15(17):2309-20. PubMed ID: 27341160
[TBL] [Abstract][Full Text] [Related]
5. Novel opioid cyclic tetrapeptides: Trp isomers of CJ-15,208 exhibit distinct opioid receptor agonism and short-acting κ opioid receptor antagonism.
Ross NC; Reilley KJ; Murray TF; Aldrich JV; McLaughlin JP
Br J Pharmacol; 2012 Feb; 165(4b):1097-108. PubMed ID: 21671905
[TBL] [Abstract][Full Text] [Related]
6. Troglitazone suppresses c-Myc levels in human prostate cancer cells via a PPARγ-independent mechanism.
Akinyeke TO; Stewart LV
Cancer Biol Ther; 2011 Jun; 11(12):1046-58. PubMed ID: 21525782
[TBL] [Abstract][Full Text] [Related]
7. The macrocyclic tetrapeptide [D-Trp]CJ-15,208 produces short-acting κ opioid receptor antagonism in the CNS after oral administration.
Eans SO; Ganno ML; Reilley KJ; Patkar KA; Senadheera SN; Aldrich JV; McLaughlin JP
Br J Pharmacol; 2013 May; 169(2):426-36. PubMed ID: 23425081
[TBL] [Abstract][Full Text] [Related]
8. Development of a robust, sensitive and selective liquid chromatography-tandem mass spectrometry assay for the quantification of the novel macrocyclic peptide kappa opioid receptor antagonist [D-Trp]CJ-15,208 in plasma and application to an initial pharmacokinetic study.
Khaliq T; Williams TD; Senadheera SN; Aldrich JV
J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Aug; 1028():11-15. PubMed ID: 27318293
[TBL] [Abstract][Full Text] [Related]
9. The macrocyclic peptide natural product CJ-15,208 is orally active and prevents reinstatement of extinguished cocaine-seeking behavior.
Aldrich JV; Senadheera SN; Ross NC; Ganno ML; Eans SO; McLaughlin JP
J Nat Prod; 2013 Mar; 76(3):433-8. PubMed ID: 23327691
[TBL] [Abstract][Full Text] [Related]
10. Alanine analogues of [D-Trp]CJ-15,208: novel opioid activity profiles and prevention of drug- and stress-induced reinstatement of cocaine-seeking behaviour.
Aldrich JV; Senadheera SN; Ross NC; Reilley KA; Ganno ML; Eans SE; Murray TF; McLaughlin JP
Br J Pharmacol; 2014 Jul; 171(13):3212-22. PubMed ID: 24588614
[TBL] [Abstract][Full Text] [Related]
11. Tryptophan Substitution in CJ-15,208 (
Scherrer KH; Eans SO; Medina JM; Senadheera SN; Khaliq T; Murray TF; McLaughlin JP; Aldrich JV
Pharmaceuticals (Basel); 2023 Aug; 16(9):. PubMed ID: 37765026
[TBL] [Abstract][Full Text] [Related]
12. The pterocarpanquinone LQB-118 inhibits tumor cell proliferation by downregulation of c-Myc and cyclins D1 and B1 mRNA and upregulation of p21 cell cycle inhibitor expression.
Martino T; Magalhães FC; Justo GA; Coelho MG; Netto CD; Costa PR; Sabino KC
Bioorg Med Chem; 2014 Jun; 22(12):3115-22. PubMed ID: 24794748
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis, and Characterization of the Macrocyclic Tetrapeptide
Ferracane MJ; Brice-Tutt AC; Coleman JS; Simpson GG; Wilson LL; Eans SO; Stacy HM; Murray TF; McLaughlin JP; Aldrich JV
ACS Chem Neurosci; 2020 May; 11(9):1324-1336. PubMed ID: 32251585
[TBL] [Abstract][Full Text] [Related]
14. Versatile Picklocks To Access All Opioid Receptors: Tuning the Selectivity and Functional Profile of the Cyclotetrapeptide c[Phe-d-Pro-Phe-Trp] (CJ-15,208).
De Marco R; Bedini A; Spampinato S; Cavina L; Pirazzoli E; Gentilucci L
J Med Chem; 2016 Oct; 59(19):9255-9261. PubMed ID: 27607020
[TBL] [Abstract][Full Text] [Related]
15. GLIPR1 suppresses prostate cancer development through targeted oncoprotein destruction.
Li L; Ren C; Yang G; Fattah EA; Goltsov AA; Kim SM; Lee JS; Park S; Demayo FJ; Ittmann MM; Troncoso P; Thompson TC
Cancer Res; 2011 Dec; 71(24):7694-704. PubMed ID: 22025562
[TBL] [Abstract][Full Text] [Related]
16. Nascent structure-activity relationship study of a diastereomeric series of kappa opioid receptor antagonists derived from CJ-15,208.
Dolle RE; Michaut M; Martinez-Teipel B; Seida PR; Ajello CW; Muller AL; DeHaven RN; Carroll PJ
Bioorg Med Chem Lett; 2009 Jul; 19(13):3647-50. PubMed ID: 19464172
[TBL] [Abstract][Full Text] [Related]
17. SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoprotein.
Geng C; Kaochar S; Li M; Rajapakshe K; Fiskus W; Dong J; Foley C; Dong B; Zhang L; Kwon OJ; Shah SS; Bolaki M; Xin L; Ittmann M; O'Malley BW; Coarfa C; Mitsiades N
Oncogene; 2017 Aug; 36(33):4767-4777. PubMed ID: 28414305
[TBL] [Abstract][Full Text] [Related]
18. RB activation and repression of C-MYC transcription precede apoptosis of human prostate epithelial cells.
Zhao X; Day ML
Urology; 2001 May; 57(5):860-5. PubMed ID: 11337282
[TBL] [Abstract][Full Text] [Related]
19. The Dual Inhibition of RNA Pol I Transcription and PIM Kinase as a New Therapeutic Approach to Treat Advanced Prostate Cancer.
Rebello RJ; Kusnadi E; Cameron DP; Pearson HB; Lesmana A; Devlin JR; Drygin D; Clark AK; Porter L; Pedersen J; Sandhu S; Risbridger GP; Pearson RB; Hannan RD; Furic L
Clin Cancer Res; 2016 Nov; 22(22):5539-5552. PubMed ID: 27486174
[TBL] [Abstract][Full Text] [Related]
20. Metformin targets c-MYC oncogene to prevent prostate cancer.
Akinyeke T; Matsumura S; Wang X; Wu Y; Schalfer ED; Saxena A; Yan W; Logan SK; Li X
Carcinogenesis; 2013 Dec; 34(12):2823-32. PubMed ID: 24130167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
